Stockholders' Equity

9 Months Ended

Sep. 25, 2011

Stockholders' Equity

Stockholders' Equity

Note 5. Stockholders’ Equity

On February 11, 2011, the Company sold approximately 4.9 million shares of its common stock at a purchase price of $13.25 per share in an underwritten public offering. The Company received gross proceeds of approximately $64.8 million. After deducting underwriting and other offering expenses, the Company received approximately $61.1 million in net proceeds.

On July 27, 2011, pursuant to the Integral Merger Agreements, the Company issued approximately 10.4 million shares of its common stock to shareholders of Integral. See Note 2 for a complete description.

A summary of the changes in stockholders’ equity is provided below (in millions):

	Nine Months EndedSeptember 26, 2010		Nine Months EndedSeptember 25, 2011
Stockholders’ equity at beginning of period	$	124.9	$	169.9
Comprehensive income:
Net income (loss)	14.1		(15.6		)
Foreign currency translation	—		0.1
Total comprehensive income (loss)	14.1		(15.5		)
Additional paid-in-capital from the issuance of common stock for cash	—		61.1
Additional paid-in-capital from the issuance of common stock for acquisitions	—		111.6
Stock-based compensation	1.4		2.3
Employee stock purchase plan and restricted stock units settled in cash	0.6		0.8
Exercise of stock options and warrants	1.3		1.2
Stockholders’ equity at end of period	$	142.3	$	331.4

In prior reporting periods, the Company had two classes of outstanding stock, Series B Convertible Preferred Stock and common stock. On March 8, 2011, all of the 10,000 shares of the previously issued and outstanding shares of Series B Convertible Preferred Stock were redeemed for 100,000 shares of common stock. Common stock issued by the Company for the nine months ended September 26, 2010 and September 25, 2011, was as follows (in millions):

	Nine Months Ended September 26, 2010	Nine Months Ended September 25, 2011
Shares outstanding at beginning of the period	15.8	18.6
Stock issued for employee stock purchase plan, stock options and restricted stock units exercised	0.2	0.4
Redemption of Series B Convertible Preferred Stock	—	0.1
Common stock issued for cash	—	15.3
Shares outstanding at end of the period	16.0	34.4